Immediate Impact
3 from Science/Nature 60 standout
Citing Papers
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
Type 2 diabetes
2022 Standout
Works of Shih‐Tzer Tsai being referenced
First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
2011
Relative role of insulin resistance and β-cell dysfunction in the progression to type 2 diabetes—The Kinmen Study
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Shih‐Tzer Tsai | 612 | 370 | 157 | 43 | 1.1k | |
| Mathew John | 554 | 220 | 119 | 50 | 968 | |
| P. S. N. Menon | 562 | 285 | 122 | 47 | 1.1k | |
| Fangzhen Xia | 326 | 283 | 142 | 59 | 1.2k | |
| P. C. Y. Tong | 422 | 285 | 120 | 35 | 893 | |
| María Luisa Granada | 558 | 195 | 130 | 66 | 1.2k | |
| Mauro Boronat | 817 | 241 | 124 | 65 | 1.3k | |
| Alison Nankervis | 495 | 192 | 226 | 70 | 1.3k | |
| Arshad Iqbal Wani | 468 | 148 | 110 | 63 | 1.2k | |
| Baihui Xu | 356 | 372 | 153 | 31 | 952 | |
| Parjeet Kaur | 545 | 544 | 225 | 27 | 1.1k |
All Works
Loading papers...